Air Canada is taking the lead in being able to ensure no COVID carrying pax board its planes. The carrier is working with Spartan Bioscience Inc. to assess how best to deploy portable COVID-19 test kits in the aviation sector.
The Ottawa-based tech company is developing a proprietary swab for the collection of DNA samples for its COVID-19 test, subject to Health Canada approval.
“Air Canada’s strategy for managing COVID-19 has been to develop and apply multiple layers of biosafety measures for customers and employees. We believe the availability of a rapid, accurate, portable molecular test for COVID-19 will add yet another effective layer. We are excited by the potential and point of care use cases for the Spartan Cube, and look forward to working with the Spartan team in the weeks and months ahead,” said Samuel Elfassy, Vice President, Safety at Air Canada.
As it adapted its procedures to operate safely during the pandemic, Air Canada was among the first carriers globally to require face coverings onboard and the first in the Americas to take customers’ temperatures prior to boarding. In MAY, it introduced a series of health and safety protocols as part of its CleanCare+ program.
“Spartan is excited to explore how our fast, portable testing technology can help keep Air Canada employees and the travelling public safe as Canada’s economy re-opens,” said Nick Noreau, Spartan Bioscience’s Chief Revenue Officer.
Anna Kroupina Journalist
Anna is OJ’s newest member and she joins the team as a writer/reporter. She co-writes the daily news and covers events. Although she’s new to the industry, pursuing a career path in travel/tourism has been a goal since her first family road trip to the Florida Keys sparked a desire to discover the world and this exhilarating, fast-paced industry.